Genomics England – The Generation Study – CAH included

The Generation Study is being carried out by Genomics England in partnership with the NHS. It is exploring the possible use of genome sequencing in newborn babies to identify a wide range of rare genetic conditions alongside the routine newborn blood spot screening. The study will include 100,000 newborns and the first participants are expected to join the study in the next few weeks.
As part of the study, Genomics England have created a list of rare conditions and associated genes that they will be looking for – and CAH is included. These conditions are chosen by following four key principles.
An extract of the list showing the types of CAH which are included is below:
Condition Group | Gene | Condition name |
Congenital adrenal hyperplasia | CYP17A1 | 17-alpha-hydroxylase/17,20-lyase deficiency |
Congenital adrenal hyperplasia | CYP21A2 *This gene meets the principles to be included, however it is not currently being analysed due to further internal work being required | Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Congenital adrenal hyperplasia | CYP11B1 | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency |
Congenital adrenal hyperplasia | HSD3B2 | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency |
The list is being kept under constant review throughout the study and is subject to change as new evidence emerges. Genomics England is working with the NHS in England to ensure availability of treatments and to confirm that the genome sequencing technology used in the study can reliably identify changes in the genes causing these conditions.
The results of the study will add to evidence that will inform future decisions on using whole genome sequencing to support newborn screening. This includes using it to accelerate diagnosis and access to treatments for rare conditions.
More information
Genomics England homepage – https://www.genomicsengland.co.uk/
The Generation Study – https://www.genomicsengland.co.uk/initiatives/newborns
Recent Blog Posts
What you should know about COVID-19 – updated 10th August 2021
Guidance from other organizations is continually being issued and we'll do our best to link to them below - please keep checking back here for more updates. UPDATE 10th August 2021 Article: “ChAdOx1 SARS‐CoV‐2 vaccination: A putative precipitant of adrenal crises”...
Support Group Meeting: London, June 2025
SUNDAY 8 June 2025 11:00-16:00 NVCO, London, N1 9RL A friendly and welcoming space for those with CAH, their families and friends to meet and learn more about the condition. If you are a member of the CAH Support Group, you will receive a password in the latest...
Webinar: The Art of Parenting While Sick – 27 March
The Addison's Disease Self-Help Group (ADSHG) is hosting a webinar titled "The Art of Parenting While Sick" on March 27, 2025. Led by Hilary Hodge, who personally manages her own adrenal insufficiency, the session aims to equip parents with effective, age-appropriate...
Drug shortage alert: injectable hydrocortisone
The Department of Health and Social Care (DHSC) has confirmed an upcoming shortage of hydrocortisone sodium phosphate for emergency injection kits from the end of February 2025, with supply expected to resume in May 2026. Find more information about this on the...